Bixiye
Homozygous Familial Hypercholesterolemia (HoFH) Agents - Medicaid
Prior Authorization, Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Natiijooyinka Raadinta
Soo bandhiga 2081 - 2090 ee natiijooyinka 3690
Bixiye
Northera® (droxidopa) - Commercial
Prior Authorization, Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
QP72-21 Commercial and MHCP Pharmacy Benefit Exclusion for Saphnelo
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2021
Bixiye
QP71-21 Provider Sharing of Protected Health Information (PHI) with Care Coordinators for Minnesota Health Care Program Members
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2021
Bixiye
QP73-21 Medical Drug Update – RSV Health Alert and Palivizumab (Synagis)
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2021
Bixiye
QP74-21 Chantix Recall and Shortage
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 22, 2021
Bixiye
Alinia® (nitazoxanide) - Medicaid
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024
Bixiye
Alinia® (nitazoxanide) - Commercial
Quantity Limit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2024
Bixiye
QP70-21 Commercial Pharmacy Benefit Update – Revised Drug-Related Prior Authorization (PA) Requirement Notification – Effective November 1, 2021
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 08, 2021
Bixiye
Elmiron® (pentosan polysulfate sodium) - Medicaid
Oggolaanshaha Hore
Taariikhda uu Dhaqangalayo Barnaamijka: Sep 01, 2024